IDDST-2023
Program Layout

 Section 1: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum

 

Section 2: Latest Development in Drug Discovery S & T

IDDST 211: Frontiers in Pharmacology, Toxicology and Drug Metabolism

IDDST 212: Innovative Drug Discovery Technology
 

Section 3: Breaking Preclinical Research and Development
IDDST 311: Cancer Drug Targets      

IDDST 312: CNS and Neurodegenerative Drug Discovery & Targets

IDDST 313: Autoimmune and Inflammation Drug Targets

IDDST 314: Advances in Medicinal Chemistry, Drug Design and Synthesis 

 

Section 4: From Clinical Applications to Drug Manufacturing
IDDST 411: Cancers/Tumors     

IDDST 412: CNS and Neurodegenerative Disorders      

IDDST 413: Emerging Infectious Diseases       

IDDST 414: Cardiovascular Disease and Metabolic Diseases      

IDDST 415: Inflammation and Immunological Diseases

IDDST 416: Orphan Diseases & Other Diseases

IDDST 417: Immunotherapy, Cell and Gene Therapy         

IDDST 418: Development of Therapeutic Antibodies, Vaccines, Protein and Peptide  

IDDST 419: Advanced Natural Products  

IDDST 420: Pharmacovigilance, Drug Manufacturing and Integrative Services
 

Section 5: Young Scientists Forum

 

 

© 2003-2023 All rights reserved by BITeomics
Contact Us: Tel:0086-411-84799609,Email:Irene@iddst.com
备案号:辽ICP备08007502号